<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00862628</url>
  </required_header>
  <id_info>
    <org_study_id>NO-003</org_study_id>
    <nct_id>NCT00862628</nct_id>
  </id_info>
  <brief_title>The Effect of Rebamipide for Non-steroidal Anti-inflammatory Drugs (NSAID) - Induced Small-intestinal Injuries</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nagoya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nagoya University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of rebamipide for NSAID-induced
      small-intestinal injuries.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">October 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of mucosal breaks</measure>
    <time_frame>4 and 8 weeks after treatment</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>NSAIDs-induced Small-intestinal Injuries</condition>
  <arm_group>
    <arm_group_label>Rebamipide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rebamipide</intervention_name>
    <description>100mg tid, 4 or 8 weeks</description>
    <arm_group_label>Rebamipide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  20 to 85 years of age

          -  RA, OA, or low back pain

          -  No change of drugs before 3 months

          -  Under 5 mg of corticosteroid use

          -  CRP &lt; 1mg/dl

          -  Small-intestinal mucosal injuries more than one

          -  Hemoglobin level is below normal range

        Exclusion Criteria:

          -  Known or suspected small-bowel disease, including Crohn's disease and seronegative
             arthritis

          -  Prostaglandins, metronidazole or salazosulfapyridine

          -  Can not swallow

          -  Eith pacemaker

          -  After gastrointestinal operation

          -  Serious concomitant cardiovascular, endocrine, gastrointestinal(including symptoms of
             ileus), neurologic, psychiatric, renal, or respiratory disease.

          -  Taking rebamipide before one week

          -  Any other conditions that the investigator feels would interfere with data
             interpretation or create under risk.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naoki Ohmiya, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nagoya University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Naoki Ohmiya, MD., Ph.D.</last_name>
    <phone>81-52-744-2172</phone>
    <email>nohmiya@med.nagoya-u.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastroenterology, Nagoya University Graduate School of Medicine</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi Prefecture</state>
        <zip>466-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Naoki Ohmiya, M.D., Ph.D.</last_name>
      <phone>81-52-744-2172</phone>
      <email>nohmiya@med.nagoya-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Naoki Ohmia, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Gastroenterology, Nagoya University Graduate School of Medicine</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi Prefecture</state>
        <zip>466-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Naoki Ohmiya, M.D., Ph.D.</last_name>
      <phone>81-52-744-2172</phone>
      <email>nohmiya@med.nagoya-u.ac.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2009</study_first_submitted>
  <study_first_submitted_qc>March 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2009</study_first_posted>
  <last_update_submitted>September 18, 2009</last_update_submitted>
  <last_update_submitted_qc>September 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Department of Gastroenterology</name_title>
    <organization>Nagoya University Graduate School of Medicine</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
    <mesh_term>Rebamipide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

